newsfilter
← Latest News
Business Wire·

Exact Sciences Schedules First Quarter 2025 Earnings Call

Exact Sciences Corp. (NASDAQ:EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company plans to release its first quarter 2025 financial results after the close of the U.S.